In the original article, there was a mistake in Table 1 as published. The heading “miR-BARTs” has been removed and the heading “BART miRNA cluster 1&2” has been replaced with “Others.” In addition, reference 22 has been added to rows 3 and 10 under “Others.” The corrected Table 1 appears below.
Table 1
| miRNA | Host targeting genes | Target | References | EBV infected cells |
|---|---|---|---|---|
| BART miRNAs cluster 1 | ||||
| miR-BART1-3p | IL12B | Adaptive immunity | (22) | LCL |
| miR-BART1-5p | LY75 | Adaptive immunity | (23) | LCL |
| miR-BART1-5p, 3p | IFI30 | Adaptive immunity | (24) | LCL |
| miR-BART15-3p | NLRP3 | Innate immunity | (25) | BL |
| miR-BART16-5p | CREBBP | Innate immunity | (26) | BL, EBVaGC |
| miR-BART17-5p | TAP2 | Adaptive immunity | (24) | LCL |
| miR-BART6-3p | RIG-I | Innate immunity | (27) | NPC |
| BART miRNAs cluster 2 | ||||
| miR-BART18-5p | MAP3K2 | BCR signals, Adaptive Immunity | (28) | BL |
| miR-BART8-5p, 3p | STAT1 | Innate immunity | (29) | NKTL |
| miR-BART22-3p | IL12B | Adaptive immunity | (22) | LCL |
| miR-BART10-3p | IL12B | Adaptive immunity | (22) | LCL |
| miR-BART20-5p | IFNG | Innate immunity | (29) | NKTL |
| Others | ||||
| miR BARTs | NF-kB signal | Innate immunity | (30) | NPC |
| miR-BART2-5p | MICB | Immunoreaction against NK cell | (31) | LCL |
| miR-BART2-5p | IL12B | Adaptive immunity | (22, 32) | LCL |
| miR-BART2-5p | CSTB | Adaptive immunity | (24) | LCL |
| miR-BART2-5p | LGMN | Adaptive immunity | (24) | LCL |
| miR-BHRF1 | IL-1R1 | Innate immunity | (33) | LCL |
| miR-BHRF1-2-5p | MALT1 | BCR signals, Adaptive Immunity | (34) | LCL, DLBL |
| miR-BHRF1-2-5p | GRB2 | BCR signals, Adaptive Immunity | (34) | LCL, DLBL |
| miR-BHRF1-2-5p | PAG1 | BCR signals, Adaptive Immunity | (34) | LCL, DLBL |
| miR-BHRF1-2-3p | IL12B | Adaptive immunity | (22, 32) | LCL |
| miR-BHRF1-2-3p | CSTB | Adaptive immunity | (24) | LCL |
| miR-BHRF1-2-3p | TAP2 | Adaptive immunity | (24) | LCL |
| miR-BHRF1-3-5p | CXCL-11 | Innate immunity | (35) | BL, DLBCL |
EBV miRNAs targeting host immune related genes.
LCL, Lymphoblastoid cell lines; BL, Burkitt lymphoma; NPC, Nasopharengeal carcinoma; EBVaGC, EBV asspciated gastridc carcinoma; NKTL, NK/T lymphoma; DLBCL, Diffuce large B cell lymphoma.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
microRNAs, herpes virus, immune evasion, BART miRNA, BHRF miRNA
Citation
Iizasa H, Kim H, Kartika AV, Kanehiro Y and Yoshiyama H (2020) Corrigendum: Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases. Front. Immunol. 11:498. doi: 10.3389/fimmu.2020.00498
Received
03 March 2020
Accepted
04 March 2020
Published
03 April 2020
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
11 - 2020
Updates
Copyright
© 2020 Iizasa, Kim, Kartika, Kanehiro and Yoshiyama.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hironori Yoshiyama yosiyama@med.shimane-u.ac.jp
This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.